Business Segments · Segment assets
Specialty Diagnostics — Segment assets
Thermo Fisher Scientific Specialty Diagnostics — Segment assets increased by 0.7% to $1.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $1.3B to $1.33B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Assets
How to read this metric
An increase may indicate capital expansion or investment in growth, while a decrease could signal asset divestment or improved capital efficiency.
Detailed definition
This metric represents the total book value of assets specifically allocated to the Specialty Diagnostics operating segm...
Peer comparison
Comparable to segment-specific asset bases reported by life science and diagnostic peers like Danaher or Abbott Laboratories.
Metric ID:
tmo_segment_specialty_diagnostics_segment_assetsHistorical Data
9 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $6.01B | $5.54B | $1.15B | $1.23B | $1.22B | $1.3B | $1.31B | $1.32B | $1.33B |
| QoQ Change | — | -7.8% | -79.2% | +7.3% | -1.3% | +6.6% | +0.7% | +1.2% | +0.7% |
| YoY Change | — | -7.8% | -79.2% | — | +5.9% | — | +5.9% | +8.6% | +2.6% |
Range$1.15B – $6.01B
CAGR-52.9%
Avg YoY Growth-10.7%
Median YoY Growth+4.3%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's specialty diagnostics — segment assets?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — segment assets of $1.33B in Q1 2026.
- How has Thermo Fisher Scientific's specialty diagnostics — segment assets changed year-over-year?
- Thermo Fisher Scientific's specialty diagnostics — segment assets increased by 2.6% year-over-year, from $1.3B to $1.33B.
- What does specialty diagnostics — segment assets mean?
- The total value of all assets dedicated to the Specialty Diagnostics business unit.